Hester Biosciences Limited (NSE:HESTERBIO)
India · Delayed Price · Currency is INR 2,083.00
-34.70 (-1.64%)
Sep 12, 2025, 3:30 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 17.67 billion as of September 12, 2025. Its market cap has decreased by -15.07% in one year.
Market Cap
17.67B
Enterprise Value
19.96B
Revenue
3.15B
Ranking
n/a
PE Ratio
47.00
Stock Price
2,083.00
Market Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 17.67B, an increase of 80,048.61%. That is a compound annual growth rate of 25.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 17.67B | -13.23% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | 14.53B | 18.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.10B |
| Divi's Laboratories | 1,601.17B |
| Cipla | 1,260.74B |
| Apollo Hospitals Enterprise | 1,140.07B |
| Mankind Pharma | 1,072.76B |
| Zydus Lifesciences | 1,046.08B |
| Fortis Healthcare | 729.25B |
| Alkem Laboratories | 644.87B |